<- Go Home
Adagio Medical Holdings, Inc.
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
Market Cap
$13.0M
Volume
719.2K
Cash and Equivalents
$4.7M
EBITDA
-$25.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$2.0M
Profit Margin
1468.61%
52 Week High
$4.20
52 Week Low
$0.63
Dividend
N/A
Price / Book Value
-9.93
Price / Earnings
-0.08
Price / Tangible Book Value
-0.59
Enterprise Value
$30.3M
Enterprise Value / EBITDA
-1.20
Operating Income
-$26.8M
Return on Equity
210.36%
Return on Assets
-24.12
Cash and Short Term Investments
$4.7M
Debt
$22.0M
Equity
-$1.3M
Revenue
$137.0K
Unlevered FCF
-$11.5M
Sector
Health Care Equipment and Supplies
Category
N/A